557 followers
RT @FrontImmunol: New Research: GD2-targeting therapy: a comparative analysis of approaches and promising directions: Disialoganglioside GD…
RT @FrontImmunol: New Research: GD2-targeting therapy: a comparative analysis of approaches and promising directions: Disialoganglioside GD…
New Research: GD2-targeting therapy: a comparative analysis of approaches and promising directions: Disialoganglioside GD2 is a promising target for immunotherapy with expression primarily restricted to neuroectodermal and epithelial tumor… https://t.co/db
GD2-targeting therapy: a comparative analysis of approaches and promising directions https://t.co/nIO1NePnYg #FrontImmunol